Fig. 5From: Concept and application of the probability of pharmacological success (PoPS) as a decision tool in drug development: a position paperCase 4. Probability distributions of AUC:MIC for the candidate drug (left) and the benchmark drug regimen (right) that gave target mean bacterial decline. The lack of any overlap between the two distributions indicated negligible PoPS for the candidate drugBack to article page